Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-24 Sale | 2026-06-24 4:26 pm | Centessa Pharmaceuticals plc | CNTA | Medicxi Ventures Management (Jersey) Ltd Medicxi Ventures I LP Medicxi Co-Invest I LP Medicxi Ventures I GP Ltd Medicxi Growth I LP Medicxi Growth Co-Invest I LP Medicxi Growth I GP Ltd Medicxi Secondary I LP Medicxi Secondary Co-Invest I LP Medicxi Secondary I GP Ltd. 10% Owner | 19,963,157 | $0 | $0 | 0 (Indirect) | View |
| 2026-06-24 Sale | 2026-06-24 4:23 pm | Centessa Pharmaceuticals plc | CNTA | INDEX VENTURES LIFE VI (JERSEY) L.P. Yucca (Jersey) SLP Index Venture Life Associates VI Ltd 10% Owner | 9,961,789 | $0 | $0 | 0 (Indirect) | View |
| 2026-06-24 Sale | 2026-06-24 4:17 pm | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J Chief Legal Officer | 123,145 | $0 | $0 | 0 (Indirect Direct) | View |
| 2026-06-24 Sale | 2026-06-24 4:17 pm | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 147,954 | $0 | $0 | 0 (Direct) | View |
| 2026-06-24 Sale | 2026-06-24 4:16 pm | Centessa Pharmaceuticals plc | CNTA | Crowley John J Chief Financial Officer | 45,000 | $0 | $0 | 0 (Direct) | View |
| 2026-06-24 Sale | 2026-06-24 4:16 pm | Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer | 62,085 | $0 | $0 | 0 (Direct) | View |
| 2026-06-24 Sale | 2026-06-24 4:16 pm | Centessa Pharmaceuticals plc | CNTA | Deferiere Raphael Chief Accounting Officer | 11,000 | $0 | $0 | 0 (Direct) | View |
| 2026-06-24 Sale | 2026-06-24 4:16 pm | Centessa Pharmaceuticals plc | CNTA | Kanes Stephen Chief Medical Officer | 120,000 | $0 | $0 | 0 (Direct) | View |
| 2026-06-24 Sale | 2026-06-24 4:16 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto Chief Executive Officer | 243,282 | $0 | $0 | 0 (Direct) | View |
| 2026-06-24 Sale | 2026-06-24 4:16 pm | Centessa Pharmaceuticals plc | CNTA | De Rubertis Francesco Director | 19,963,157 | $0 | $0 | 0 (Indirect) | View |
| 2026-06-24 Sale | 2026-06-24 4:15 pm | Centessa Pharmaceuticals plc | CNTA | GOYAL ARJUN Director | 462,585 | $0 | $0 | 0 (Indirect Direct) | View |
| 2026-06-24 Sale | 2026-06-24 4:15 pm | Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Business Officer | 65,925 | $0 | $0 | 0 (Indirect Direct) | View |
| 2026-03-26 Sale | 2026-03-27 6:17 pm | Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer | 41,076 | $30.12 | $1,237,382 | 146,009 (Direct) | View |
| 2026-03-26 Sale | 2026-03-26 8:36 pm | Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Business Officer | 23,998 | $30 | $719,940 | 96,927 (Direct) | View |
| 2026-03-16 Sale | 2026-03-18 6:43 pm | Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer | 74,811 | $28.19 | $2,109,180 | 222,128 (Direct) | View |
| 2026-03-13 Sale(A) | 2026-03-16 6:09 pm | Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer | 120,029 | $26.25 | $3,150,673 | 240,232 (Direct) | View |
| 2026-03-13 Sale | 2026-03-13 6:23 pm | Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer | 120,029 | $26.25 | $3,150,673 | 196,722 (Direct) | View |
| 2026-03-13 Sale | 2026-03-13 6:22 pm | Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Business Officer | 73,196 | $26.33 | $1,927,131 | 65,925 (Direct) | View |
| 2026-01-30 Sale | 2026-02-03 6:59 pm | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J Chief Legal Officer | 39,961 | $25.15 | $1,004,918 | 283,145 (Indirect Direct) | View |
| 2025-12-09 Sale | 2025-12-09 7:07 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 10,000 | $28.83 | $288,289 | 178,801 (Direct) | View |
| 2025-12-08 Sale | 2025-12-08 6:26 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 10,000 | $30 | $300,000 | 195,051 (Direct) | View |
| 2025-11-17 Sale | 2025-11-18 4:18 pm | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $27.64 | $165,835 | 326,945 (Direct) | View |
| 2025-11-17 Sale | 2025-11-18 4:17 pm | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 40,000 | $28 | $1,120,000 | 481,841 (Direct) | View |
| 2025-11-12 Sale | 2025-11-13 5:02 pm | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 40,000 | $26 | $1,040,000 | 521,841 (Direct) | View |
| 2025-10-27 Sale | 2025-10-27 7:56 pm | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 8,000 | $25 | $200,000 | 224,394 (Direct) | View |
| 2025-10-15 Sale | 2025-10-16 4:13 pm | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $22.41 | $134,439 | 338,445 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-01 Tax Withholding | 2026-05-18 9:44 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto Chief Executive Officer | 604 | $39.42 | 243,282 (Direct) | View |
| 2026-03-26 Exercise | 2026-03-27 6:17 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer | 41,076 | $8.01 | 146,009 (Direct) | View |
| 2026-03-26 Exercise | 2026-03-27 6:17 pm | N/A 2034-02-01 | Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer | 41,076 | $0 | 146,009 (Direct) | View |
| 2026-03-26 Exercise | 2026-03-26 8:36 pm | N/A 2033-02-01 | Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Business Officer | 23,998 | $0 | 96,927 (Direct) | View |
| 2026-03-26 Exercise | 2026-03-26 8:36 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Business Officer | 23,998 | $3.85 | 96,927 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-18 6:43 pm | N/A 2032-12-01 | Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer | 74,811 | $0 | 222,128 (Direct) | View |
| 2026-03-16 Exercise | 2026-03-18 6:43 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer | 74,811 | $4.01 | 222,128 (Direct) | View |
| 2026-03-13 Exercise(A) | 2026-03-16 6:09 pm | N/A 2032-12-01 | Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer | 109,398 | $0 | 240,232 (Direct) | View |
| 2026-03-13 Exercise(A) | 2026-03-16 6:09 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer | 15,174 | $3.85 | 240,232 (Direct) | View |
| 2026-03-13 Exercise(A) | 2026-03-16 6:09 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer | 94,224 | $4.01 | 240,232 (Direct) | View |
| 2026-03-13 Exercise | 2026-03-13 6:23 pm | N/A 2032-12-01 | Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer | 109,398 | $0 | 196,722 (Direct) | View |
| 2026-03-13 Exercise | 2026-03-13 6:23 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer | 109,398 | $4.01 | 196,722 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-03 7:03 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Kanes Stephen Chief Medical Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-03 7:02 pm | N/A 2036-02-02 | Centessa Pharmaceuticals plc | CNTA | Crowley John J Chief Financial Officer | 226,000 | $0 | 226,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-03 7:01 pm | N/A 2036-02-02 | Centessa Pharmaceuticals plc | CNTA | Deferiere Raphael Chief Accounting Officer | 53,000 | $0 | 53,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-03 6:59 pm | N/A 2036-02-02 | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J Chief Legal Officer | 220,000 | $0 | 283,145 (Direct) | View |
| 2026-02-01 Tax Withholding | 2026-02-03 6:59 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J Chief Legal Officer | 7,780 | $24.57 | 283,145 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-03 6:57 pm | N/A 2036-02-02 | Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Business Officer | 154,000 | $0 | 262,121 (Direct) | View |
| 2026-02-01 Tax Withholding | 2026-02-03 6:57 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Weinhoff Gregory M Chief Business Officer | 14,158 | $24.57 | 262,121 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-03 6:55 pm | N/A 2036-02-02 | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto Chief Executive Officer | 341,000 | $0 | 516,886 (Direct) | View |
| 2026-02-01 Tax Withholding | 2026-02-03 6:55 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto Chief Executive Officer | 2,915 | $24.57 | 516,886 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-03 6:54 pm | N/A 2036-02-02 | Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer | 146,000 | $0 | 189,716 (Direct) | View |
| 2026-02-01 Tax Withholding | 2026-02-03 6:54 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Anderson Karen M. Chief People Officer | 10,606 | $24.57 | 189,716 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-03 6:52 pm | N/A 2036-02-02 | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 175,000 | $0 | 287,954 (Direct) | View |
| 2026-02-01 Tax Withholding | 2026-02-03 6:52 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 8,549 | $24.57 | 287,954 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-08 6:26 pm | N/A 2032-02-01 | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 5,000 | $0 | 195,051 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-08 6:26 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 5,000 | $9.53 | 195,051 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-18 4:18 pm | N/A 2031-02-19 | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $0 | 326,945 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-18 4:18 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $5.84 | 326,945 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-18 4:17 pm | N/A 2031-05-07 | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 40,000 | $0 | 481,841 (Direct) | View |
| 2025-11-17 Exercise | 2025-11-18 4:17 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 40,000 | $9.42 | 481,841 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-13 5:02 pm | N/A 2031-05-07 | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 40,000 | $0 | 521,841 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-13 5:02 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Bush Tia L Chief Technology & Quality Ofc | 40,000 | $9.42 | 521,841 (Direct) | View |
| 2025-11-01 Tax Withholding | 2025-11-03 4:14 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 593 | $24.9 | 193,801 (Direct) | View |
| 2025-10-27 Exercise | 2025-10-27 7:56 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 5,000 | $8.01 | 224,394 (Direct) | View |
| 2025-10-27 Exercise | 2025-10-27 7:56 pm | N/A 2034-02-01 | Centessa Pharmaceuticals plc | CNTA | Accardi Mario Alberto President, Orexin Program | 5,000 | $0 | 224,394 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-16 4:13 pm | N/A 2031-02-19 | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $0 | 338,445 (Direct) | View |
| 2025-10-15 Exercise | 2025-10-16 4:13 pm | N/A N/A | Centessa Pharmaceuticals plc | CNTA | HUSSAIN IQBAL J General Counsel | 6,000 | $5.84 | 338,445 (Direct) | View |